Medios 

Medios: The valuation is too attractive to ignore the stock!

I find a projected P/E ratio of under 8 too cheap!
The healthcare company benefits from demographic change and the desire for patient-specific medicine!
Marvin Herzberger
M. Herzberger
Reading Time: 2 minutes

Currently, uncertainty is again growing in the stock market. In such phases, investors increasingly seek out more defensive industries and sectors. They are finding opportunities in the healthcare sector, particularly with Medios AG (i.). The company is transforming into an integrated European solution provider for complex therapies. In the long term, demographic change plays in the company’s favor. As standard medications are insufficient for many complex and rare medical conditions, the demand for patient-specific therapies is continuously...

Read this article now with a free account.

Your benefits:

  • Every month, you can read 5 articles from the premium section for free.
  • Monthly 2 trial issues of the Trader newspaper for free.
  • Create a personal watchlist with an overview of news about your stock.
Trader Times
Free account
Here we go!
Image 1Image 2Image 3

Already registered? Log In